Rhumbline Advisers Astellas Pharma Inc Unsponsore Transaction History
Rhumbline Advisers
- $121 Billion
- Q3 2025
A detailed history of Rhumbline Advisers transactions in Astellas Pharma Inc Unsponsore stock. As of the latest transaction made, Rhumbline Advisers holds 24,846 shares of ALPMY stock, worth $304,611. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,846
Previous 31,138
20.21%
Holding current value
$304,611
Previous $303,000
10.89%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ALPMY
# of Institutions
9Shares Held
318KCall Options Held
0Put Options Held
0-
Hantz Financial Services, Inc.225KShares$2.76 Million0.04% of portfolio
-
Nbc Securities, Inc. Birmingham, AL57.1KShares$699,4940.05% of portfolio
-
Gamma Investing LLC Foster City, CA8.74KShares$107,1520.01% of portfolio
-
Private Capital Group, LLC1.09KShares$13,3140.01% of portfolio
-
Salomon & Ludwin, LLC817Shares$10,0160.0% of portfolio
About Astellas Pharma Inc Unsponsore
- Ticker ALPMY
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,827,069,952
- Market Cap $22.4B